NR3C2 and Hyperkalemia: Additionally, although only one small trial has been conducted with mineralocorticoid receptor antagonists, such as spironolactone, in the HD population, showing no statically significant increase in hyperkalemia, these diuretics should be prescribed with high caution [59].